+
データを開く
-
基本情報
登録情報 | データベース: PDB / ID: 1h9o | ||||||
---|---|---|---|---|---|---|---|
タイトル | PHOSPHATIDYLINOSITOL 3-KINASE, P85-ALPHA SUBUNIT: C-TERMINAL SH2 DOMAIN COMPLEXED WITH A TYR751 PHOSPHOPEPTIDE FROM THE PDGF RECEPTOR, CRYSTAL STRUCTURE AT 1.79 A | ||||||
![]() |
| ||||||
![]() | TRANSFERASE/RECEPTOR / COMPLEX (PHOSPHOTRANSFERASE-RECEPTOR) / PHOSPHOTRANSFERASE / SH2 DOMAIN / SIGNAL TRANSDUCTION / PHOSPHOINOSITIDE 3-KINASE / TRANSFERASE-RECEPTOR complex | ||||||
機能・相同性 | ![]() platelet-derived growth factor receptor activity / cell migration involved in coronary angiogenesis / metanephric glomerular mesangial cell proliferation involved in metanephros development / platelet activating factor receptor activity / cell migration involved in vasculogenesis / positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway / smooth muscle cell chemotaxis / metanephric glomerular capillary formation / aorta morphogenesis / positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway ...platelet-derived growth factor receptor activity / cell migration involved in coronary angiogenesis / metanephric glomerular mesangial cell proliferation involved in metanephros development / platelet activating factor receptor activity / cell migration involved in vasculogenesis / positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway / smooth muscle cell chemotaxis / metanephric glomerular capillary formation / aorta morphogenesis / positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway / smooth muscle adaptation / platelet-derived growth factor binding / vascular endothelial growth factor binding / perinuclear endoplasmic reticulum membrane / regulation of toll-like receptor 4 signaling pathway / retina vasculature development in camera-type eye / phosphatidylinositol kinase activity / positive regulation of focal adhesion disassembly / phosphatidylinositol 3-kinase activator activity / 1-phosphatidylinositol-3-kinase regulator activity / positive regulation of endoplasmic reticulum unfolded protein response / phosphatidylinositol 3-kinase regulator activity / IRS-mediated signalling / cardiac myofibril assembly / interleukin-18-mediated signaling pathway / T follicular helper cell differentiation / Signaling by PDGF / positive regulation of chemotaxis / phosphatidylinositol 3-kinase complex / myeloid leukocyte migration / PI3K events in ERBB4 signaling / phosphatidylinositol 3-kinase regulatory subunit binding / neurotrophin TRKA receptor binding / Activated NTRK2 signals through PI3K / cis-Golgi network / ErbB-3 class receptor binding / Activated NTRK3 signals through PI3K / transmembrane receptor protein tyrosine kinase adaptor activity / phospholipase C activator activity / Signaling by cytosolic FGFR1 fusion mutants / Co-stimulation by ICOS / RHOD GTPase cycle / platelet-derived growth factor receptor binding / RHOF GTPase cycle / phosphatidylinositol 3-kinase complex, class IA / kinase activator activity / Nephrin family interactions / Signaling by LTK in cancer / positive regulation of leukocyte migration / Signaling by LTK / MET activates PI3K/AKT signaling / PI3K/AKT activation / negative regulation of stress fiber assembly / RND1 GTPase cycle / positive regulation of filopodium assembly / RND2 GTPase cycle / RND3 GTPase cycle / positive regulation of smooth muscle cell migration / insulin binding / growth hormone receptor signaling pathway / positive regulation of DNA biosynthetic process / Signaling by ALK / RHOB GTPase cycle / RHOV GTPase cycle / PI-3K cascade:FGFR3 / natural killer cell mediated cytotoxicity / Erythropoietin activates Phosphoinositide-3-kinase (PI3K) / GP1b-IX-V activation signalling / PI-3K cascade:FGFR2 / PI-3K cascade:FGFR4 / PI-3K cascade:FGFR1 / positive regulation of calcium ion import / RHOC GTPase cycle / platelet-derived growth factor receptor-beta signaling pathway / RHOJ GTPase cycle / intracellular glucose homeostasis / negative regulation of osteoclast differentiation / platelet-derived growth factor receptor signaling pathway / phosphatidylinositol phosphate biosynthetic process / Synthesis of PIPs at the plasma membrane / RHOU GTPase cycle / CDC42 GTPase cycle / RET signaling / PI3K events in ERBB2 signaling / insulin receptor substrate binding / Interleukin-3, Interleukin-5 and GM-CSF signaling / PI3K Cascade / T cell differentiation / RHOG GTPase cycle / extrinsic apoptotic signaling pathway via death domain receptors / negative regulation of cell-matrix adhesion / platelet-derived growth factor beta-receptor activity / RHOA GTPase cycle / CD28 dependent PI3K/Akt signaling / Role of LAT2/NTAL/LAB on calcium mobilization / RAC2 GTPase cycle / RAC3 GTPase cycle / Interleukin receptor SHC signaling / Role of phospholipids in phagocytosis / enzyme-substrate adaptor activity 類似検索 - 分子機能 | ||||||
生物種 | ![]() | ||||||
手法 | ![]() ![]() | ||||||
![]() | Pauptit, R.A. / Rowsell, S. / Breeze, A.L. / Murshudov, G.N. / Dennis, C.A. / Derbyshire, D.J. / Weston, S.A. | ||||||
![]() | ![]() タイトル: NMR Trial Models: Experiences with the Colicin Immunity Protein Im7 and the P85Alpha C-Terminal Sh2-Peptide Complex 著者: Pauptit, R.A. / Dennis, C.A. / Derbyshire, D.J. / Breeze, A.L. / Weston, S.A. / Rowsell, S. / Murshudov, G.N. | ||||||
履歴 |
|
-
構造の表示
構造ビューア | 分子: ![]() ![]() |
---|
-
ダウンロードとリンク
-
ダウンロード
PDBx/mmCIF形式 | ![]() | 39.6 KB | 表示 | ![]() |
---|---|---|---|---|
PDB形式 | ![]() | 27 KB | 表示 | ![]() |
PDBx/mmJSON形式 | ![]() | ツリー表示 | ![]() | |
その他 | ![]() |
-検証レポート
文書・要旨 | ![]() | 438.5 KB | 表示 | ![]() |
---|---|---|---|---|
文書・詳細版 | ![]() | 440.8 KB | 表示 | |
XML形式データ | ![]() | 8.7 KB | 表示 | |
CIF形式データ | ![]() | 11.6 KB | 表示 | |
アーカイブディレクトリ | ![]() ![]() | HTTPS FTP |
-関連構造データ
関連構造データ | ![]() 1picS S: 精密化の開始モデル |
---|---|
類似構造データ |
-
リンク
-
集合体
登録構造単位 | ![]()
| ||||||||
---|---|---|---|---|---|---|---|---|---|
1 |
| ||||||||
単位格子 |
| ||||||||
詳細 | HETERODIMER CONSISTING OF P110 AND P85-ALPHA . THEC-TERMINAL SH2-DOMAIN (CHAIN A) IS A FRAGMENT OFP85-ALPHA. THE PENTAPEPTIDE (CHAIN B) IS A FRAGMENT OFPLATELET DERIVED GROWTH FACTOR RECEPTOR. CHAINSA AND B FORM A COMPLEX REPRESENTATIVE OF THEINTERACTION BETWEEN PI3 KINASE AND PDGF-RECEPTOR. |
-
要素
#1: タンパク質 | 分子量: 12612.094 Da / 分子数: 1 断片: C-TERMINAL SH2 DOMAIN, P85-ALPHA REGULATORY SUBUNIT RESIDUES 617 - 724 由来タイプ: 組換発現 詳細: CONTAINS AN N-TERMINAL EXTENSION (GSPI) DERIVED FROM THE RECOMBINANT EXPRESSION VECTOR 由来: (組換発現) ![]() ![]() ![]() | ||
---|---|---|---|
#2: タンパク質・ペプチド | 分子量: 701.767 Da / 分子数: 1 / 断片: RESIDUES 751 - 755 / 由来タイプ: 合成 / 詳細: TYROSINE-PHOSPHORYLATED PENTAPEPTIDE / 由来: (合成) ![]() | ||
#3: 水 | ChemComp-HOH / | ||
構成要素の詳細 | PHOSPHATIDHas protein modification | Y | |
-実験情報
-実験
実験 | 手法: ![]() |
---|
-
試料調製
結晶 | マシュー密度: 2.1 Å3/Da / 溶媒含有率: 43 % / 解説: NMR TRIAL MODEL |
---|---|
結晶化 | pH: 7 詳細: 40MG/ML PROTEIN IN 20 MM PHOSPHATE PH6.2 + PEG8000, RESERVOIR WITH SAME PHOSPHATE + PEG8000 + 250MM NACL, pH 7.00 |
結晶化 | *PLUS 手法: 蒸気拡散法, ハンギングドロップ法 |
-データ収集
回折 | 平均測定温度: 287 K |
---|---|
放射光源 | 由来: ![]() |
検出器 | タイプ: MARRESEARCH / 検出器: IMAGE PLATE / 日付: 1995年9月15日 |
放射 | モノクロメーター: GRAPHITE / プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
放射波長 | 波長: 1.5418 Å / 相対比: 1 |
反射 | 解像度: 1.79→54 Å / Num. obs: 9283 / % possible obs: 93 % / Observed criterion σ(I): 0 / 冗長度: 4 % / Rmerge(I) obs: 0.05 / Rsym value: 0.05 |
反射 | *PLUS Num. measured all: 36576 |
-
解析
ソフトウェア |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
精密化 | 構造決定の手法: ![]() 開始モデル: PDB ENTRY 1PIC 解像度: 1.79→54 Å / SU B: 4.2 / SU ML: 0.134 / 交差検証法: THROUGHOUT / σ(F): 0 / ESU R: 0.154 / ESU R Free: 0.147 / 詳細: HYDROGENS ADDED IN RIDING POSITIONS
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
原子変位パラメータ | Biso mean: 18.9 Å2
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化ステップ | サイクル: LAST / 解像度: 1.79→54 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
拘束条件 |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ソフトウェア | *PLUS 名称: REFMAC / 分類: refinement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
拘束条件 | *PLUS
|